Autolus Therapeutics (AUTL) Change in Inventory (2024 - 2025)

Autolus Therapeutics (AUTL) posted quarterly Change in Inventory of $10.1 million for Q4 2025, up 139.06% year-on-year from $4.2 million in Q4 2024, and up 17.53% on a QoQ basis from $8.6 million in Q3 2025.

Autolus Therapeutics (AUTL) Change in Inventory (2024 - 2025) Analysis & Trends

Autolus Therapeutics (AUTL) has reported Change in Inventory for 2 consecutive years, with $10.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Change in Inventory rose 139.06% year-over-year to $10.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.2 million (up 851.76% YoY) and the FY2025 annual result came in at $40.2 million, up 851.76% from the prior year.
  • Change in Inventory rose to $10.1 million in Q4 2025 per AUTL's latest filing, from $8.6 million in the prior quarter.
  • Over the last five years, Change in Inventory for AUTL reached as high as $11.4 million in Q2 2025 and fell as low as $4.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Autolus Therapeutics 404.53 Mn 103.82 Mn -1.04 Mn 10.11 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.11 Mn
Dec 31, 2025 10.11 Mn
Sep 30, 2025 8.60 Mn
Sep 30, 2025 8.60 Mn
Jun 30, 2025 11.44 Mn
Jun 30, 2025 11.44 Mn
Mar 31, 2025 10.10 Mn
Mar 31, 2025 10.10 Mn
Dec 31, 2024 4.23 Mn
Dec 31, 2024 4.23 Mn